Cardiovascular disease in postmenopausal women

Climacteric

Volumn 6, Issue SUPPL. 3, 2003, Pages 13-20

  Regitz Zagrosek, V ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cardiac surgery; Cardiovascular disease; Endothelin 1; Estrogen receptors; Postmenopausal women

Indexed keywords

ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; ENDOTHELIN 1; ESTROGEN; ESTROGEN RECEPTOR; INSULIN; NEUROHORMONE; PROTEIN;

ADIPOCYTE; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ACTIVITY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART SURGERY; HUMAN; HYPERTENSION; MALE; MORTALITY; POSTMENOPAUSE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTMENOPAUSE; RISK FACTORS; SEX FACTORS;

EID: 1642456648     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Franklin SS, Gustin W, IV, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: The Framingham Heart Study. Circulation 1997;96:308-15
2. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens 1989;3:427-33
3. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971;285:1441-6
4. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13
5. Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 1997;126:761-7
6. MacMahon SW, Cutler JA, Furberg CD, Payne GH. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis 1986;29:99-118
7. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068-72
8. Vittinghoff E, Shlipak MG, Varosy PD, et al. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2003;138:81-9
9. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33
10. Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 2002;20:965-73
11. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 2002;51:1699-707
12. Boschmann M, Jordan J, Schmidt S, Adams F, Luft FC, Klaus S. Gender-specific response to interstitial angiotension II in human white adipose tissue. Horm Metab Res 2002;34:726-30
13. Sharma AM, Janke J, Gorzelniak K, Engeli S, Luft FC. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 2002;40:609-11
14. Yusuf S, Gerstein H, Hoogwerf B, et al. Ramipril and the development of diabetes. J Am Med Assoc 2001;286:1882-5
15. Haynes MP, Sinha D, Russell KS, et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the P13-kinase-Akt pathway in human endothelial cells. Circ Res 2000;87:677-82
16. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407:538-41
17. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002;53:672-7
18. Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002;89:12-17E; discussion 17-18E
19. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 2002;90:3-6F
20. Sherman TS, Chambliss KL, Gibson LL, et al. Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. Am J Respir Cell Mol Biol 2002;26:610-16